Treatment of atopic dermatitis with a combination of allergen-specific immunotherapy and a histamine-immunoglobulin complex

International Archives of Allergy and Immunology

Volumn 146, Issue 3, 2008, Pages 235-240

  Nahm, Dong Ho ^a   Lee, Eun So ^a   Park, Han Jung ^a   Kim, Hyoun Ah ^a   Choi, Gil Soon ^a   Jeon, Sook Yeong ^b  

^a Ajou University Medical Center   (South Korea)

^b Yonsei Ajou Pediatric Clinic   (South Korea)

Author keywords

Allergen; Atopic dermatitis; Histamine immunoglobulin complex; House dust mite; Immunotherapy

Indexed keywords

HISTAMINE; HISTAMINE IMMUNOGLOBULIN COMPLEX; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN; PREDNISOLONE;

ADOLESCENT; ADULT; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS; FEMALE; HUMAN; IMMUNOTHERAPY; LOW DRUG DOSE; MALE; PILOT STUDY; PRIORITY JOURNAL; SCHOOL CHILD; SCORING SYSTEM; SEVERITY SCORING SYSTEM FOR ATOPIC DERMATITIS; SKIN MANIFESTATION; WILCOXON SIGNED RANKS TEST;

ADOLESCENT; ADULT; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; CHILD; DERMATITIS, ATOPIC; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HISTAMINE; HUMANS; IMMUNOGLOBULINS; MALE; PATIENT COMPLIANCE; PILOT PROJECTS; STATISTICS, NONPARAMETRIC;

EID: 45149097670     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000115892     Document Type: Article

References (27)

1. Hanifin JM, Cooper KD, Ho VC, Kang S, Krafchik BR, Margolis DJ, et al: Guidelines of care for atopic dermatitis. J Am Acad Dermatol 2004;50:391-404.
2. Ellis C, Luger T, Abeck D, Allen R, Graham-Brown RA, De Prost Y, et al: International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies. Br J Dermatol 2003;148:3-10.
3. Akdis CA, Akdis M, Bieber T, Bindslev-Jensen C, Boguniewicz M, Eigenmann P, et al: Diagnosis and treatments of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol 2006;118:152-169.
4. Flohr C, Johansson SGO, Wahlgren CF, Williams H: How atopic is atopic dermatitis? J Allergy Clin Immunol 2005;114:150-158.
5. Novak N, Bieber T, Leung DYM: Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol 2003;112:S128-S139.
6. Platts-Mills TA, Mitchell EB, Rowntree S, Chapman MD, Wilkins SR: The role of dust mite allergens in atopic dermatitis. Clin Exp Dermatol 1983;8:233-247.
7. Tupker RA, De Monchy JG, Coenraads PJ, Homan A, van der Meer JB: Induction of atopic dermatitis by inhalation of house dust mite. J Allergy Clin Immunol 1996;97:1064-1070.
8. Tan BB, Weald D, Strickland I, Friedmann PS: Double-blind controlled trial of effect of house dust-mite allergen avoidance on atopic dermatitis. Lancet 1996;347:15-18.
9. Bousquet J, Lockey R, Malling HJ, WHO panel members: Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 1998;102:558-562.
10. Glover MT, Atherton DJ: A double-blind controlled trial of hyposensitization to Dermatophagoides pteronyssinus in children with atopic eczema. Clin Exp Allergy 1992;22:440-446.
11. Clinical Research Group for Histaglobin: Double blind controlled study on the efficacy of histaglobin on chronic urticaria and eczematous dermatitis (in Japanese). Nishinipponifuka 1980;42:470-477.
12. Yoshii H, Fukata-Yamazaki Y, Yamamoto K, Yago H, Yanagihara Y, Okudaira H: A complex of histamine/mouse gamma-globulin preferentially inhibits allergen-induced peritoneal accumulation of eosinophils, but not neutrophils, in mice. J Allergy Clin Immunol 1997;100:809-816.
13. Gelfand HH, Cinder JC, Grant SF, Soiffer M: Evaluation of histamine-gamma globulin (histaglobin) in the treatment of various allergic conditions. Ann Allergy 1963;21:150-155.
14. Ayoub M, Lallouette P, Sutterlin BW, Bessler WG, Huber M, Mittenbuhler K: Modulation of the Th1/Th2 bias by an immunoglobulin histamine complex in the ovalbumin allergy mouse model. Int Immunopharmacol 2003;3:523-539.
15. Hanifin JM, Rajka G: Diagnostic features of atopic eczema. Acta Derm Venereol (Stockh) 1980;92:44-47.
16. European Task Force on Atopic Dermatitis: Severity scoring of atopic dermatitis: the SCORAD index. Dermatology 1993;186:23-31.
17. Griffin CE, Hillier A: The ACVD task force on canine atopic dermatitis (XXIV): allergen-specific immunotherapy. Vet Immunol Immunopathol 2001;81:363-383.
18. Werfel T, Breuer K, Ruéff F, Przybilla B, Worm M, Grewe M, et al: Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-dependent study. Allergy 2006;61:202-205.
19. Bussmann C, Bockenhoff A, Henke H, Werfel T, Novak N: Does allergen-specific immunotherapy represent a therapeutic option for patients with atopic dermatitis. J Allergy Clin Immunol 2006;118:1292-1298.
20. Leory BP, Boden G, Lachapelle JM, Jacquemin MG, Saint-Remy JM: A novel therapy for atopic dermatitis with allergen-antibody complexes: a double-blind, placebo-controlled study. J Am Acad Dermatol 1993;28:232-239.
21. Hoare C, Li Wan Po A, Williams H: Systematic review of treatments of atopic eczema. Health Technol Assess 2000;4:1-191.
22. Mueller RS, Veir J, Fieseler KV, Dow SW: Use of immunostimulatory liposome-nucleic acid complexes in allergen-specific immunotherapy of dogs with refractory atopic dermatitis - a pilot study. Vet Dermatol 2005;16:61-68.
23. Ohashi Y, Nakai Y, Tanaka A, Kakinoki Y, Washio Y, Ohno Y, et al: Risk factors for adverse systemic reactions occurring during immunotherapy with standardized Dermatophagoides farinae extracts. Acta Otolaryngol Suppl 1998;538:113-117.
24. Ohashi Y, Nakai Y, Kiyotaka M: Effect of pretreatment with fexofenadine on the safety of immunotherapy in patients with allergic rhinitis. Ann Allergy Asthma Immunol 2006;4:600-605.
25. Lane JE, Cheyney JM, Lane TN, Kent DE, Cohen DJ: Treatment of recalcitrant atopic dermatitis with omalizumab. J Am Acad Dermatol 2006;54:68-72.
26. Krathen RA, Hsu S: Failure of omalizumab for treatment of severe adult atopic dermatitis. J Am Acad Dermatol 2005;53:338-340.
27. Hochhaus G, Brookman L, Fox H, Johnson C, Matthews J, Ren S, Deniz Y: Pharmacodynamics of omalizumab: implications for optimized dosing strategies and clinical efficacy in the treatment of allergic asthma. Curr Med Res Opin 2003;19:491-498.